{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:58:36Z","timestamp":1781056716986,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Qingdao Technology Bureau","award":["13-1-3-34-nsh"],"award-info":[{"award-number":["13-1-3-34-nsh"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2018MH031"],"award-info":[{"award-number":["ZR2018MH031"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.toxicon.2019.12.153","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T12:19:41Z","timestamp":1577103581000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling"],"prefix":"10.1016","volume":"178","author":[{"given":"Xiaojuan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-7662","authenticated-orcid":false,"given":"Chengfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2019.12.153_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pain.2013.11.003","article-title":"Etifoxine analgesia in experimental monoarthritis: a combined action that protects spinal inhibition and limits central inflammatory processes","volume":"155","author":"Aouad","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2019.12.153_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012","article-title":"Central origin of the antinociceptive action of botulinum toxin type A","volume":"94","author":"Bach-Rojecky","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.toxicon.2019.12.153_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1474-4422(16)00056-9","article-title":"Fighting neuropathic pain with botulinum toxin A","volume":"15","author":"Baron","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/0022034516653604","article-title":"Microglial signaling in chronic pain with a special focus on caspase 6, p38 MAP kinase, and sex dependence","volume":"95","author":"Berta","year":"2016","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.toxicon.2019.12.153_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","volume":"2","author":"Brin","year":"1987","journal-title":"Mov. Disord. : Off. J. Movement Disorder Soc."},{"key":"10.1016\/j.toxicon.2019.12.153_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3959(92)90133-V","article-title":"A limited arthritic model for chronic pain studies in the rat","volume":"48","author":"Butler","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2019.12.153_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2017.10.027","article-title":"Direct central nervous system effects of botulinum neurotoxin","volume":"147","author":"Caleo","year":"2018","journal-title":"Toxicon : Off. J. Int. Soc. Toxinol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib8","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1523\/JNEUROSCI.0294-18.2018","article-title":"Transynaptic action of botulinum neurotoxin type A at central cholinergic boutons","volume":"38","author":"Caleo","year":"2018","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.toxicon.2019.12.153_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.expneurol.2011.08.018","article-title":"The mechanisms of microgliosis and pain following peripheral nerve injury","volume":"234","author":"Calvo","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0394632015593220","article-title":"Safety and efficacy of intra-articular anti-tumor necrosis factor alpha agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare","volume":"29","author":"Carubbi","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.toxicon.2019.12.153_bib12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.toxicon.2019.12.153_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2019.12.153_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.toxicon.2017.05.001","article-title":"Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain","volume":"133","author":"Fan","year":"2017","journal-title":"Toxicon : Off. J. Int. Soc. Toxinol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029803","article-title":"Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy","volume":"7","author":"Filipovic","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2019.12.153_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0036-1594284","article-title":"Botulinum toxin injections in musculoskeletal disorders","volume":"20","author":"Godoy","year":"2016","journal-title":"Semin. Musculoskelet. Radiol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2005.03.007","article-title":"Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain","volume":"163","author":"Guo","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2019.12.153_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.toxicon.2019.12.153_bib20","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/jnr.23443","article-title":"P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain","volume":"92","author":"Jin","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.toxicon.2019.12.153_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.micro.53.1.551","article-title":"Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins","volume":"53","author":"Johnson","year":"1999","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fphar.2017.00048","article-title":"Blockade of P2X4 receptors inhibits neuropathic pain-related behavior by preventing MMP-9 activation and, consequently, pronociceptive interleukin release in a rat model","volume":"8","author":"Jurga","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib23","article-title":"Botulinum neurotoxin type A induces TLR2-mediated inflammatory responses in macrophages","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2019.12.153_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd1177","article-title":"p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases","volume":"2","author":"Kumar","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxicon.2019.12.153_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12974-018-1285-3","article-title":"Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation","volume":"15","author":"Long","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.toxicon.2019.12.153_bib27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pain.2013.12.009","article-title":"Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior","volume":"155","author":"Marino","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2019.12.153_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","article-title":"Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A","volume":"186","author":"Matak","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2019.12.153_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11080459","article-title":"Mechanisms of botulinum toxin type A action on pain","volume":"11","author":"Matak","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2019.12.153_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.toxicon.2019.12.153_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.intimp.2019.02.042","article-title":"Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways","volume":"70","author":"Nasseri","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/14728222.2017.1353603","article-title":"Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients?","volume":"21","author":"Nijs","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.toxicon.2019.12.153_bib33","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2004.01.007","article-title":"MAPK activation in nociceptive neurons and pain hypersensitivity","volume":"74","author":"Obata","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.toxicon.2019.12.153_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060224","article-title":"Botulinum toxin for central neuropathic pain","volume":"10","author":"Park","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2019.12.153_bib35","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.3390\/toxins7114519","article-title":"Current status and future directions of botulinum neurotoxins for targeting pain processing","volume":"7","author":"Pellett","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2019.12.153_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081999","article-title":"Dual-specificity phosphatase regulation in neurons and glial cells","volume":"20","author":"Perez-Sen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxicon.2019.12.153_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fcimb.2017.00141","article-title":"Comparison of the expression changes after botulinum toxin type A and minocycline administration in lipopolysaccharide-stimulated rat microglial and astroglial cultures","volume":"7","author":"Piotrowska","year":"2017","journal-title":"Front. Cell. Infection Microbiol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2015.01.033","article-title":"Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke","volume":"350","author":"Santamato","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.toxicon.2019.12.153_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nbd.2007.02.007","article-title":"Is functional state of spinal microglia involved in the anti-allodynic and anti-hyperalgesic effects of electroacupuncture in rat model of monoarthritis?","volume":"26","author":"Shan","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.toxicon.2019.12.153_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.trsl.2009.02.004","article-title":"Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial","volume":"153","author":"Singh","year":"2009","journal-title":"Transl. Res. : J. Lab. Clin. Med."},{"key":"10.1016\/j.toxicon.2019.12.153_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yexcr.2018.05.012","article-title":"Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway","volume":"369","author":"Sun","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.toxicon.2019.12.153_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bj.2017.06.010","article-title":"P2X4: a fast and sensitive purinergic receptor","volume":"40","author":"Suurvali","year":"2017","journal-title":"Biomed. J."},{"key":"10.1016\/j.toxicon.2019.12.153_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2013.01.088","article-title":"Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and mu opioid receptor expression in neuropathic mice","volume":"32","author":"Vacca","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.toxicon.2019.12.153_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/glia.22596","article-title":"P2X4 receptors control the fate and survival of activated microglia","volume":"62","author":"Vazquez-Villoldo","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.toxicon.2019.12.153_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrrheum.2014.64","article-title":"Mechanisms, impact and management of pain in rheumatoid arthritis","volume":"10","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxicon.2016.11.009","article-title":"Intra-articular injection of Botulinum toxin A reduces neurogenic inflammation in CFA-induced arthritic rat model","volume":"126","author":"Wang","year":"2017","journal-title":"Toxicon : Off. J. Int. Soc. Toxinol."},{"key":"10.1016\/j.toxicon.2019.12.153_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12640-013-9447-7","article-title":"Anti-inflammatory effects of botulinum toxin type a in a complete Freund's adjuvant-induced arthritic knee joint of hind leg on rat model","volume":"26","author":"Yoo","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxicon.2019.12.153_bib48","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00296-013-2715-2","article-title":"Cellular events during arthritis-induced hyperalgesia are mediated by interleukin-6 and p38 MAPK and their effects on the expression of spinal mu-opioid receptors","volume":"33","author":"Zaringhalam","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.toxicon.2019.12.153_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/WNR.0000000000000769","article-title":"Spinal microglial P2X4 receptor-brain-derived neurotrophic factor signaling regulates nicotine withdrawal-induced hyperalgesia","volume":"28","author":"Zhang","year":"2017","journal-title":"Neuroreport"},{"key":"10.1016\/j.toxicon.2019.12.153_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2017.04.060","article-title":"Olfactory ensheathing cell transplantation inhibits P2X4 receptor overexpression in spinal cord injury rats with neuropathic pain","volume":"651","author":"Zheng","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxicon.2019.12.153_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010119309158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010119309158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:14:30Z","timestamp":1758575670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010119309158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":51,"alternative-id":["S0041010119309158"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2019.12.153","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2019.12.153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}